POPULATION STABILITY IN TUMOR DORMANCY
POPULATION STABILITY IN TUMOR DORMANCY
批准号:
2896642
负责人:
RICHARD H SCHEUERMANN
金额:
$24.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2003-05-31
关键词:
SCID mouse apoptosis biological signal transduction cell cycle cell growth regulation cell population study cell proliferation enzyme activity flow cytometry immunoprecipitation laboratory mouse lymphoma mathematical model neoplasm /cancer remission /regression neoplastic process polymerase chain reaction protein tyrosine kinase protooncogene single cell analysis tissue /cell culture video microscopy western blottings
中文摘要
肿瘤休眠,一种恶性肿瘤静止的状态,
已经被很好地记录了几种人类癌症。一个重要的
休眠的含义是,在某些情况下,恶性的
肿瘤可以受到生长抑制。小鼠BCL1淋巴瘤
系统提供了一种实验模型,其中休眠可以
可重复地建立和研究。先前的工作表明,
休眠是通过信号转导途径在这个系统中诱导的。
来源于膜免疫球蛋白(MIG)。在体外,参与
MIG诱导细胞周期停滞(CCA),细胞周期进展和
细胞凋亡,以及Lyn和Syk酪氨酸激酶的激活。在……里面
此外,在Long和Long中,淋巴瘤细胞数量保持不变
在长期培养和休眠动物中,表明细胞周期
进展必须通过细胞死亡来平衡。我们的工作假设是
I)LYN的激活对于CCA响应和Syk对于
凋亡反应;ii)细胞周期进程和凋亡
在这些单元中相互连接;iii)这种连接导致
一个子细胞死亡而另一个子细胞死亡的不对称细胞分裂
在细胞周期中继续进行;iv)这种平衡是
对体内肿瘤休眠至关重要。
这个项目的具体目标是:1.确定关系
CCA、细胞周期进程、细胞凋亡和种群稳定性
在抗Ig治疗的淋巴瘤培养中。2.确定余额是否
导致人口长期稳定的增长和死亡之间的关系
在文化上是通过在两个随机的
种群中的过程或涉及不对称的定向过程
细胞分裂。3.改变BCL1.3B3中Syk和Lyn激酶的活性
并确定对CCA、细胞周期进程、细胞凋亡和
体外种群稳定性。4.确定Syk中的更改如何
而Lyn激酶活性影响诱导、维持和逃逸
在活体内休眠。
我们研究的长期目标是-识别信号
转导级联反应控制细胞凋亡和细胞周期进程,
确定这些过程与体内肿瘤的关系
生长(尤其是肿瘤休眠,这是一种相对未经探索的临床
问题),并利用这些知识进行改进的设计
治疗方法。此外,人口有可能
稳定性由不对称的细胞分裂决定,平衡生长和
死亡是一种新事物,对理解肿瘤具有重要意义
从根本上控制增长和正常的人口动态平衡。
英文摘要
Tumor dormancy, a state in which a malignant tumor becomes quiescent,
has been well documented for several human cancers. An important
implication of dormancy is that under certain circumstances a malignant
tumor can be brought under growth restraint. The mouse BCL1 lymphoma
system provides an experimental model in which dormancy can be
reproducibly established and investigated. Previous work indicates that
dormancy is induced in this system through signal transduction pathways
originating from membrane immunoglobulin (mIg). In vitro, engagement
of mIg induces cell cycle arrest (CCA), cell cycle progression and
apoptosis, and the activation of the Lyn and Syk tyrosine kinases. In
addition, the lymphoma cell population remains constant both in long
term cultures and in dormant animals, indicating that cell cycle
progression must be balanced by cell death. Our working hypotheses are
that i) activation of Lyn is important for the CCA response and Syk for
the apoptotic response; ii) cell cycle progression and apoptosis are
interconnected in these cells; iii) this connection results in an
asymmetric cell division in which one daughter cell dies while the other
continues to progress through the cell cycle; iv) this balance is
essential for tumor dormancy in vivo.
The specific aims of this project are: 1. To determine the relationship
between CCA, cell cycle progression, apoptosis and population stability
in anti-Ig-treated lymphoma cultures. 2. To determine if the balance
between growth and death that results in long term population stability
in culture is achieved by an overall balance between two stochastic
processes in the population or as directed process involving asymmetric
cell division. 3. To alter Syk and Lyn kinase activities in BCL1.3B3
and determine effects on CCA, cell cycle progression, apoptosis and
population stability in vitro. 4. To determine how alterations in Syk
and Lyn kinase activities affect the induction, maintenance and escape
of dormancy in vivo.
The long term objectives of our studies are - to identify signal
transduction cascades controlling apoptosis and cell cycle progression,
to determine the relationship between these processes and in vivo tumor
growth (especially tumor dormancy, a relatively unexplored clinical
problem), and to use this knowledge for the design of improved
therapeutic approaches. In addition, the possibility that population
stability is dictated by asymmetric cell division balancing growth and
death is novel and has important implications for understanding tumor
growth control and normal population homeostasis at a fundamental level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Somatic Mutation in the Etiology of Multiple Sclerosis
-
批准号:9180380
-
项目类别:
-
资助金额:$35.67万
-
财政年份:2016
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Bioinformatics Resource Center
-
批准号:8147328
-
项目类别:
-
资助金额:$6.09万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Bioinformatics Resource Center
-
批准号:8693850
-
项目类别:
-
资助金额:$430.83万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:--
Bioinformatics Resource Center
-
批准号:8867924
-
项目类别:
-
资助金额:$0.63万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:--
Bioinformatics Resource Center
-
批准号:8147336
-
项目类别:
-
资助金额:$115.66万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Bioinformatics Resource Center
-
批准号:8513846
-
项目类别:
-
资助金额:$65.59万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Bioinformatics Resource Centers
-
批准号:8513847
-
项目类别:
-
资助金额:$65.59万
-
财政年份:2009
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
BISC PHASE II
-
批准号:7543645
-
项目类别:
-
资助金额:$740.93万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:--
Bioinformatics Integration Support Contract for Biodefense
-
批准号:7891935
-
项目类别:
-
资助金额:$689.93万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Bioinformatics Integration Support Contract for Biodefense
-
批准号:8151533
-
项目类别:
-
资助金额:$339.95万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
BIOINFORMATICS RESOURCE CENTERS FOR BIODEFENSE
-
批准号:7543671
-
项目类别:
-
资助金额:$342.64万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:--
BIOINFORMATICS RESOURCE CENTERS
-
批准号:7923430
-
项目类别:
-
资助金额:$1678.25万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
BIOINFORMATICS RESOURCE CENTERS
-
批准号:8135843
-
项目类别:
-
资助金额:$63.66万
-
财政年份:2004
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Functional Characterization of BAFF-induced Genes
-
批准号:6841176
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2003
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Functional Characterization of BAFF-induced Genes
-
批准号:6999780
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2003
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Functional Characterization of BAFF-induced Genes
-
批准号:7177536
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2003
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Functional Characterization of BAFF-induced Genes
-
批准号:6677221
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2003
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Functional Characterization of BAFF-induced Genes
-
批准号:6760112
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2003
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
Database development and modeling of signal transduction
-
批准号:6445433
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2002
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
POPULATION STABILITY IN TUMOR DORMANCY
-
批准号:6377200
-
项目类别:
-
资助金额:$25.47万
-
财政年份:1998
-
负责人:RICHARD H SCHEUERMANN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: